1. Recognizing the Many Faces of Chronic Hepatitis B Infection in the United States

2. HBV Infection: Some Sobering Facts

3. HBV Serology

4. Natural History of Acute HBV Infection

5. Acute HBV Infection

6. The Real Problem: Chronic HBV Infection

7. Chronic HBV Infection Is Silent

8. Complications of Cirrhosis and Portal Hypertension

9. Prevention Is the Best Medicine

10. Universal HBV Vaccination in United States Since 1991

11. Why Are So Many People Infected?

12. Risk for Development of Chronic Infection: Age Matters

13. Who Should Be Screened for HBV?

14. Others Who Should Be Screened for HBV

15. Chronic HBV Infection Among Asian Americans

16. Do You Ever Really Get Rid Of HBV?

17. What Happens With Immunosuppression?

18. HBV Reactivation

19. Potential for HBV Reactivation With Chemotherapy: Another Reason to Screen

20. Value of Lamivudine Prophylaxis in Patients With NHL Treated With CHOP and Reappearance of HBeAg in Serum

21. HBV Screening of All Patients With B-cell Lymphoma Treated with R-CHOP Is Cost-effective and Cost-saving

22. You Have Screened Your Patient: Now What?

23. Role of PCP in the Management of HBsAg+ Persons

24. Ongoing Monitoring by PCP

25. When Should We Treat?

26. Treatment of HBV Infection Delays Clinical Progression of HBV and Advanced Fibrosis or Cirrhosis

27. HBV DNA Undetectable After 1 Year on Treatment

28. Pretreatment Considerations for the PCP

29. Pretreatment Considerations for the PCP (cont)

30. Summary of Key Points

31. Abbreviations

32. Abbreviations (cont)

34. References (cont)

35. References (cont)